AI Verdict
MEDP has stronger fundamentals based on our AI analysis.
MEDP vs MSFT Fundamental Comparison
| Metric | MEDP | MSFT |
|---|---|---|
| Revenue | $2.5B | $158.9B |
| Net Income | $451.1M | $66.2B |
| Net Margin | 17.8% | 41.7% |
| ROE | 98.3% | 16.9% |
| ROA | 22.8% | 10.0% |
| Current Ratio | 0.74x | 1.39x |
| Debt/Equity | 0.00x | 0.10x |
| EPS | $15.28 | $8.87 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MEDP vs MSFT: Frequently Asked Questions
Is MEDP or MSFT a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MEDP has stronger fundamentals. MEDP is rated STRONG BUY (87% confidence) while MSFT is rated BUY (91% confidence). This is not investment advice.
How does MEDP compare to MSFT fundamentally?
Medpace Holdings, Inc. has ROE of 98.3% vs MICROSOFT CORP's 16.9%. Net margins are 17.8% vs 41.7% respectively.
Which stock pays higher dividends, MEDP or MSFT?
MEDP has a dividend yield of N/A or no dividend while MSFT has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MEDP or MSFT for long term?
For long-term investing, consider that MEDP has STRONG BUY rating with 87% confidence, while MSFT has BUY rating with 91% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MEDP vs MSFT?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MEDP vs MSFT, the AI consensus favors MEDP based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.